• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[幽门螺杆菌耐药性:谁需要何种治疗?]

[Helicobacter pylori resistance: who needs what treatment?].

作者信息

Courillon-Mallet Anne

机构信息

Service d'Hépato-Gastroentérologie, Centre Hospitalier Intercommunal, Villeneuve-Saint-Georges.

出版信息

Presse Med. 2006 Apr;35(4 Pt 2):657-62. doi: 10.1016/s0755-4982(06)74659-0.

DOI:10.1016/s0755-4982(06)74659-0
PMID:16614611
Abstract

The standard treatment recommended for eradication of Helicobacter pylori is a combination of three drugs for seven days: one proton pump inhibitor at a double dose and two antibiotics. The high risk of failure - on the order of 30% - justifies routine testing to verify eradication after this first treatment. Verification is most often conducted with a urea breath test, more rarely by endoscopy when endoscopy or gastric histology is otherwise necessary. When eradication fails, longer multidrug treatment with different antibiotics is proposed. The failure rate after second-line treatment is 9-10%. If a third treatment is necessary, bacterial culture is recommended to select antibiotics on the basis of the antibiotic susceptibility testing.

摘要

推荐用于根除幽门螺杆菌的标准治疗方案是三种药物联合使用七天

一种双倍剂量的质子泵抑制剂和两种抗生素。高达30%左右的高失败风险使得在首次治疗后进行常规检测以确认根除效果成为必要。确认通常通过尿素呼气试验进行,在内镜检查或胃组织学检查有其他必要情况时,较少通过内镜检查来进行。当根除失败时,建议使用不同抗生素进行更长疗程的联合治疗。二线治疗后的失败率为9 - 10%。如果需要进行第三次治疗,建议进行细菌培养,以便根据抗生素敏感性试验选择抗生素。

相似文献

1
[Helicobacter pylori resistance: who needs what treatment?].[幽门螺杆菌耐药性:谁需要何种治疗?]
Presse Med. 2006 Apr;35(4 Pt 2):657-62. doi: 10.1016/s0755-4982(06)74659-0.
2
Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance.在抗生素耐药性较低的地区,七日三联疗法是根除幽门螺杆菌的更佳选择。
World J Gastroenterol. 2015 Dec 14;21(46):13073-9. doi: 10.3748/wjg.v21.i46.13073.
3
Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.大剂量质子泵抑制剂、阿莫西林和强力霉素三联疗法对根除幽门螺杆菌无效:一项概念验证研究。
Helicobacter. 2014 Apr;19(2):90-7. doi: 10.1111/hel.12106. Epub 2014 Feb 10.
4
Selection of lower cutoff point of [13C]urea breath test is helpful to monitor H. pylori eradication after proton pump inhibitor-based triple therapy.选择[13C]尿素呼气试验的较低临界值有助于监测基于质子泵抑制剂的三联疗法后幽门螺杆菌的根除情况。
Dig Dis Sci. 2000 Jul;45(7):1330-6. doi: 10.1023/a:1005599818959.
5
Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract.原发性抗生素耐药性与幽门螺杆菌三联疗法在上消化道溃疡炎症性病变中的有效性
Acta Gastroenterol Belg. 2005 Jul-Sep;68(3):287-93.
6
[Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study].[消化性溃疡患者两次治疗失败后幽门螺杆菌根除:一项前瞻性培养指导研究]
Gastroenterol Hepatol. 2002 Aug-Sep;25(7):438-42. doi: 10.1016/s0210-5705(02)70283-5.
7
Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions.克拉霉素用于高耐药地区培养后幽门螺杆菌感染的一线治疗。
Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1380-4. doi: 10.1097/MEG.0000000000000197.
8
Quadruple rescue therapy after first and second line failure for Helicobacter pylori treatment: comparison between two tetracycline-based regimens.幽门螺杆菌治疗一线和二线失败后的四联挽救疗法:两种基于四环素的方案的比较
J Gastrointestin Liver Dis. 2014 Dec;23(4):367-70. doi: 10.15403/jgld.2014.1121.234.qrth.
9
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.在各种治疗策略中,联合治疗对幽门螺杆菌的根除率最高。
World J Gastroenterol. 2015 Jan 7;21(1):351-9. doi: 10.3748/wjg.v21.i1.351.
10
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection.幽门螺杆菌感染的流行病学、临床影响和当前临床管理。
Med J Aust. 2016 Jun 6;204(10):376-80. doi: 10.5694/mja16.00104.